Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 2019 by Dr. Yi Rao, a prominent figure in biomedical research in China, Gritgen is committed to applying "Great Science for Human Health." The company has autonomously developed globally leading platforms, namely GritPAC and GritOcul, which demonstrate high efficiency. By integrating a profound understanding of the genetics and biology of diseases with modern molecular biology technologies, Gritgen has created s...
Established in 2019 by Dr. Yi Rao, a prominent figure in biomedical research in China, Gritgen is committed to applying "Great Science for Human Health." The company has autonomously developed globally leading platforms, namely GritPAC and GritOcul, which demonstrate high efficiency. By integrating a profound understanding of the genetics and biology of diseases with modern molecular biology technologies, Gritgen has created several product pipelines addressing both rare and common diseases. The aim is to address unmet medical needs and enhance the overall health of individuals in China and globally.

List your booth number for exhibitions, ask us